179 related articles for article (PubMed ID: 21107702)
1. Mutant p53 exhibits trivial effects on mitochondrial functions which can be reactivated by ellipticine in lymphoma cells.
Wang F; Liu J; Robbins D; Morris K; Sit A; Liu YY; Zhao Y
Apoptosis; 2011 Mar; 16(3):301-10. PubMed ID: 21107702
[TBL] [Abstract][Full Text] [Related]
2. Ellipticine induces apoptosis in T-cell lymphoma via oxidative DNA damage.
Savorani C; Manfé V; Biskup E; Gniadecki R
Leuk Lymphoma; 2015 Mar; 56(3):739-47. PubMed ID: 24898668
[TBL] [Abstract][Full Text] [Related]
3. Ellipticine induces apoptosis through p53-dependent pathway in human hepatocellular carcinoma HepG2 cells.
Kuo YC; Kuo PL; Hsu YL; Cho CY; Lin CC
Life Sci; 2006 Apr; 78(22):2550-7. PubMed ID: 16337242
[TBL] [Abstract][Full Text] [Related]
4. Rescue of mutant p53 transcription function by ellipticine.
Peng Y; Li C; Chen L; Sebti S; Chen J
Oncogene; 2003 Jul; 22(29):4478-87. PubMed ID: 12881704
[TBL] [Abstract][Full Text] [Related]
5. Reactivation of mutant p53 by a dietary-related compound phenethyl isothiocyanate inhibits tumor growth.
Aggarwal M; Saxena R; Sinclair E; Fu Y; Jacobs A; Dyba M; Wang X; Cruz I; Berry D; Kallakury B; Mueller SC; Agostino SD; Blandino G; Avantaggiati ML; Chung FL
Cell Death Differ; 2016 Oct; 23(10):1615-27. PubMed ID: 27258787
[TBL] [Abstract][Full Text] [Related]
6. Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivo.
Koblish HK; Zhao S; Franks CF; Donatelli RR; Tominovich RM; LaFrance LV; Leonard KA; Gushue JM; Parks DJ; Calvo RR; Milkiewicz KL; Marugán JJ; Raboisson P; Cummings MD; Grasberger BL; Johnson DL; Lu T; Molloy CJ; Maroney AC
Mol Cancer Ther; 2006 Jan; 5(1):160-9. PubMed ID: 16432175
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrially targeted p53 or DBD subdomain is superior to wild type p53 in ovarian cancer cells even with strong dominant negative mutant p53.
Lu P; Vander Mause ER; Redd Bowman KE; Brown SM; Ahne L; Lim CS
J Ovarian Res; 2019 May; 12(1):45. PubMed ID: 31092272
[TBL] [Abstract][Full Text] [Related]
8. Ellipticine-induced apoptosis depends on Akt translocation and signaling in lung epithelial cancer cells.
Fang K; Chen SP; Lin CW; Cheng WC; Huang HT
Lung Cancer; 2009 Feb; 63(2):227-34. PubMed ID: 18619705
[TBL] [Abstract][Full Text] [Related]
9. Reactivation of wild-type and mutant p53 by tryptophanolderived oxazoloisoindolinone SLMP53-1, a novel anticancer small-molecule.
Soares J; Raimundo L; Pereira NA; Monteiro Â; Gomes S; Bessa C; Pereira C; Queiroz G; Bisio A; Fernandes J; Gomes C; Reis F; Gonçalves J; Inga A; Santos MM; Saraiva L
Oncotarget; 2016 Jan; 7(4):4326-43. PubMed ID: 26735173
[TBL] [Abstract][Full Text] [Related]
10. The mitochondrial cyclophilin D/p53 complexation mediates doxorubicin-induced non-apoptotic death of A549 lung cancer cells.
Lu JH; Shi ZF; Xu H
Mol Cell Biochem; 2014 Apr; 389(1-2):17-24. PubMed ID: 24343341
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial p53 levels parallel total p53 levels independent of stress response in human colorectal carcinoma and glioblastoma cells.
Mahyar-Roemer M; Fritzsche C; Wagner S; Laue M; Roemer K
Oncogene; 2004 Aug; 23(37):6226-36. PubMed ID: 15247902
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of glucosylceramide synthase eliminates the oncogenic function of p53 R273H mutant in the epithelial-mesenchymal transition and induced pluripotency of colon cancer cells.
Hosain SB; Khiste SK; Uddin MB; Vorubindi V; Ingram C; Zhang S; Hill RA; Gu X; Liu YY
Oncotarget; 2016 Sep; 7(37):60575-60592. PubMed ID: 27517620
[TBL] [Abstract][Full Text] [Related]
13. Suppression of glucosylceramide synthase restores p53-dependent apoptosis in mutant p53 cancer cells.
Liu YY; Patwardhan GA; Bhinge K; Gupta V; Gu X; Jazwinski SM
Cancer Res; 2011 Mar; 71(6):2276-85. PubMed ID: 21278235
[TBL] [Abstract][Full Text] [Related]
14. Jasmonates induce nonapoptotic death in high-resistance mutant p53-expressing B-lymphoma cells.
Fingrut O; Reischer D; Rotem R; Goldin N; Altboum I; Zan-Bar I; Flescher E
Br J Pharmacol; 2005 Nov; 146(6):800-8. PubMed ID: 16170329
[TBL] [Abstract][Full Text] [Related]
15. MI-63: a novel small-molecule inhibitor targets MDM2 and induces apoptosis in embryonal and alveolar rhabdomyosarcoma cells with wild-type p53.
Canner JA; Sobo M; Ball S; Hutzen B; DeAngelis S; Willis W; Studebaker AW; Ding K; Wang S; Yang D; Lin J
Br J Cancer; 2009 Sep; 101(5):774-81. PubMed ID: 19707204
[TBL] [Abstract][Full Text] [Related]
16. Decrease of mitochondrial p53 during late apoptosis is linked to its dephosphorylation on serine 20.
Castrogiovanni C; Vandaudenard M; Waterschoot B; De Backer O; Dumont P
Cancer Biol Ther; 2015; 16(9):1296-307. PubMed ID: 26252178
[TBL] [Abstract][Full Text] [Related]
17. Tid1 is a new regulator of p53 mitochondrial translocation and apoptosis in cancer.
Ahn BY; Trinh DL; Zajchowski LD; Lee B; Elwi AN; Kim SW
Oncogene; 2010 Feb; 29(8):1155-66. PubMed ID: 19935715
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial uncoupling inhibits p53 mitochondrial translocation in TPA-challenged skin epidermal JB6 cells.
Wang F; Fu X; Chen X; Chen X; Zhao Y
PLoS One; 2010 Oct; 5(10):e13459. PubMed ID: 20976134
[TBL] [Abstract][Full Text] [Related]
19. Wild-type and mutant p53 proteins interact with mitochondrial caspase-3.
Frank AK; Pietsch EC; Dumont P; Tao J; Murphy ME
Cancer Biol Ther; 2011 Apr; 11(8):740-5. PubMed ID: 21307660
[TBL] [Abstract][Full Text] [Related]
20. Dicoumarol enhances doxorubicin-induced cytotoxicity in p53 wild-type urothelial cancer cells through p38 activation.
Matsui Y; Watanabe J; Ding S; Nishizawa K; Kajita Y; Ichioka K; Saito R; Kobayashi T; Ogawa O; Nishiyama H
BJU Int; 2010 Feb; 105(4):558-64. PubMed ID: 19583730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
